EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting regulated chondrocyte death in osteoarthritis therapy

Rendi Zhu, Yan Wang, Ziwei Ouyang, Wenjuan Hao, Fuli Zhou, Yi Lin, Yuanzhi Cheng, Renpeng Zhou, Wei Hu

Biochemical Pharmacology · 2023-09 · 215 · 115707

DOI: 10.1016/j.bcp.2023.115707 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2023-09. Verfasst von Rendi Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China; The Key Laboratory of Major Autoimmune Dis…. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 200 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vivo articular cartilage degeneration is an essential hallmark of osteoarthritis (OA), involving chondrocyte senescence, extracellular matrix degradation, chondrocyte death, cartilage loss, and bone erosion. Among them, chondrocyte death is one of the major factors leading to cartilage degeneration. Many studies have reported that various cell death modes, including apoptosis, ferroptosis, and autophagy, play a key role in OA chondrocyte death. Currently, there is insufficient understanding of OA pathogenesis, and there remains a lack of treatment methods to prevent OA and inhibit its progression. Studies suggest that OA prevention and treatment are mainly directed to arrest premature or excessive chondrocyte death. In this review, we a) discuss the forms of death of chondrocytes and the associations between them, b) summarize the critical factors in chondrocyte death, c) discuss the vital role of chondrocyte death in OA, d) and, explore new approaches for targeting the regulation of chondrocyte death in OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisCartilage, ArticularHumansChondrocytesApoptosis

Stichwörter der Autor:innen

ApoptosisAutophagyChondrocyteFerroptosisNecroptosisOsteoarthritis

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui…
  • Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China; Anhui Provincial Institute of Translational Medicine, Hefei 230032, China. Electronic address: zhourenpeng@ahmu.…
  • Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China; Anhui Provincial Institute of Translational Medicine, Hefei 230032, China. Electronic address: huwei@ahmu.edu.cn.

Förderung

  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Anhui Medical University

Zitieren

APA

Zhu, R., Wang, Y., Ouyang, Z., Hao, W., Zhou, F., Lin, Y., Cheng, Y., Zhou, R., & Hu, W. (2023). Targeting regulated chondrocyte death in osteoarthritis therapy. Biochemical Pharmacology, 215, 115707. https://doi.org/10.1016/j.bcp.2023.115707

Vancouver

Zhu R, Wang Y, Ouyang Z, Hao W, Zhou F, Lin Y, et al. Targeting regulated chondrocyte death in osteoarthritis therapy. Biochemical Pharmacology. 2023;215:115707. doi:10.1016/j.bcp.2023.115707

BibTeX
@article{Zhu2023,
  author = {Zhu, Rendi and Wang, Yan and Ouyang, Ziwei and Hao, Wenjuan and Zhou, Fuli and Lin, Yi and Cheng, Yuanzhi and Zhou, Renpeng and Hu, Wei},
  title = {Targeting regulated chondrocyte death in osteoarthritis therapy},
  journal = {Biochemical Pharmacology},
  year = {2023},
  volume = {215},
  pages = {115707},
  doi = {10.1016/j.bcp.2023.115707}
}
Kostenlos starten →